On June 7, 2022, Aimed Alliance and the Partnership to Advance Cardiovascular Health hosted a webinar on HR.com titles “Non-Medical…
On June 2, 2022, Aimed Alliance released a new fact sheet on biomarker testing titled “Increase Access to Precision Medicine…
Aimed Alliance’s staff attorney, Ashira Vantrees, spoke with the Patient Empowerment Network for their May 2022 Activity Guide on “How…
On May 26, the Food and Drug Administration (FDA) sent warning letters to Free State Oils, Kingdom Harvest, Kahm CBD,…
A new report from the Alliance for Mental Health Care Access entitled The Dangers of Non-Medical Switching for Mental Health…
In March 2020, the U.S. Food and Drug Administration (FDA) recognized the need for more data to address the gaps…
On May 18, the Collaborative for Cannabinoid Science and Safety (CCSS) sent a letter to U.S. Senators Durbin and Braun…
On May 4, 2022, Johnson & Johnson filed a complaint in the United States District Court of New Jersey against…
On May 15, 2022, Aimed Alliance updated its Copay Accumulator 101 Hub to include a Frequently Asked Questions (FAQ) section.…
On May 10, 2022, Aimed Alliance launched two new maps to track active and enacted biomarker legislation. Biomarker testing can…